Modifizierte Mohnpflanze mit Erhöhtem Gehalt an Thebain

Details

Veröffentlichungs-Nr.

EP3398430

Aktenzeichen

EP18170224

Anmeldetag

1. Mai 2018

Veröffentlichung

18. September 2024

Erteilung

18. September 2024

Rechtsraum

EP

IPC

A01H5/10C12N9/02C07D489/02

Abstract

The disclosure relates to a plant of the genus Papaver that comprises one or more genomic modifications in multiple genes encoding codeine 3-O-demethylase (CODM) and which do not express detectable codeine 3-O-demethylase activity wherein said modified plant is further modified in one or more thebaine 6-O-demethylase genes (T6ODM) to reduce or abrogate thebaine 6-O-demethylase activity said plant is characterised by increased thebaine content when compared to an unmodified plant of the same species.

Anmelder

Firmen

Sun Pharmaceutical Industries Australia PTY Limited
Sun Pharmaceutical Industries Australia Limited

Land

🇦🇺 Australien

Fachgebiete